DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Menne J, Ritz E, Ruilope LM. et al.
The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) observational follow-up study: benefits of RAS blockade with olmesartan treatment are sustained after study discontinuation.
J Am Heart Assoc 2014;
3: e000810
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.